Herpes simplex-associated erythema multiforme (HAEM): a clinical therapeutic dilemma.Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adultsRabies in Israel: decades of prevention and a human case.When is an epidemic an epidemic?The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers.Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization.Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys.Eighty years of the threat and use of chemical warfare: the medical-organizational challenge.[Why viral (SARS, Ebola and AIDS) epidemics now?].Prevalence of ischemic heart disease in patients with familial Mediterranean fever.Prevalence of antibodies to West Nile fever, sandfly fever Sicilian, and sandfly fever Naples viruses in healthy adults in Israel.Seronegative spondyloarthropathy in familial Mediterranean fever.Increased prevalence of joint manifestations in patients with recurrent aphthous stomatitis (RAS)Protracted febrile myalgia in patients with familial Mediterranean fever.Colchicine in the treatment of AA and AL amyloidosis.Active versus passive immunization against hepatitis A in the Israel defence forces: a cost-benefit analysis.Structure and process components of trauma care services in Israeli acute-care hospitals.Electrical injuries: current concepts.Clinical trials of Shigella vaccines in Israel.Cytokines modulate interleukin-6 production by human salivary gland cell line.Interhospital patient transfer: a quality improvement indicator for prehospital triage in mass casualties.The efficacy of integrating "smart simulated casualties" in hospital disaster drills.Ketamine in the field: the use of ketamine for induction of anaesthesia before intubation in injured patients in the field.An argument for equipping civilian hospitals with a multiple respirator system for a chemical warfare mass casualty situation.Civilian-military health services contingency program for a mass casualty situation and wartime in Israel.Deaths following influenza vaccination--background mortality or causal connection?Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes.Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season.Sudden death in the Gulf War.Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.Trends in the epidemiology of herpes simplex virus type 1 among the young adult population in Israel.Hepatitis A antibody prevalence among young adults in Israel--the decline continues.Use of simulated bioterrorist attacks to evaluate syndromic surveillance systems based on multiple data sources.Major adverse reactions to yeast-derived hepatitis B vaccines--a review.Lancets unethical behavior.Long-term psychological and physiological effects of heat stroke.British medical journals play politics.Exertional heat stroke: a case series.Black tongue associated with minocycline therapy.
P50
Q33745801-DBCD8793-7E08-4D51-A9AF-41339DEBACA4Q34007642-316B004A-3563-4396-8C40-61A0B2CC7DE8Q34103675-F141CD02-F1F9-416F-9DB0-03BB813B3B5FQ34110376-679BE12C-DD07-4216-BFA3-62FABD06C270Q34580365-1E82EAA6-325F-465A-9FC6-559A6A01E98DQ35227169-3E2DC60C-672A-4305-B66A-708B76BF9E56Q36236044-C8E5E4C1-7455-4FE7-9FC7-BAEC56176B7CQ38496941-BD62F22B-2D15-4BCE-B7FC-EBC9F8A7AD84Q39245920-B4325141-00EF-45C8-B2B5-90EB3C423A5BQ40557006-6934B9AC-983A-46B0-94C7-566B7BC385FBQ40603169-1F4BCAEA-B119-43B8-925B-DEF9A19B7DC3Q40620811-47F9FDE3-F258-4D72-B371-29AC3ABC4585Q40645200-B844170C-93DB-4797-BACF-78F9A3797BEFQ40666403-2960DC79-D334-4D23-B4B4-3A0D483E193BQ40697152-9C8EBBB8-8874-4BF1-8E56-8D8F94978B4DQ40709737-F50FBE7A-DE62-434D-8EDF-8BD560BE4BD9Q40763950-5B6D4BE2-A594-4A79-817A-4D0F531758B4Q40851892-F8BD3D49-3A7A-42C4-996D-B3E9ABA87C63Q40940189-5A083AED-83B9-4FF6-9659-1F34484F6F5FQ41041423-3D82EC72-5188-431E-9D2B-57251E587203Q41414488-64E95200-31C4-4553-B5F9-A4413D84AECEQ42056062-92238054-4D68-413B-9152-8419E57A690EQ42056772-BE427FE1-9123-45A5-B1E9-4C46F327DF0CQ42057483-B9A1C1D2-7CBF-4332-8ACC-95B911CB9334Q42071024-ABD6FA5E-4F9A-4870-A718-763AD4E22302Q42071029-98A9C2F3-FD0D-4082-B286-9D56E370AA25Q43175963-D6815878-D126-40A0-AD92-81EC4ADDEA53Q43177540-63933212-611E-4D01-9AB0-57D8C6D68C7AQ43210905-52210D4E-633A-451B-9F86-C730F7435EEEQ44574390-790DA1C4-B9F6-4CD2-B069-67B06F7FA12DQ44920964-3BA66460-AEFF-4DEC-B247-AAAC3A06F824Q45224724-4112BEFF-E6BD-40AD-8E2F-D774211F6119Q46879603-ACE3386E-36F7-46CE-A74A-113FB887284FQ47120990-F60D5BC1-42FB-41DA-88CE-A34853B88A0EQ48026737-B203CA4C-B03D-4BAB-8931-F9DC1EE9E268Q48064195-F28F1F6A-0675-4BFE-B2E4-DC0DBCABEEACQ48237449-3CFBFC4B-4A9D-430B-99F8-D43150E3C0B5Q48261405-51A6EF48-89A9-4AA2-A57D-821CA5AFE581Q48704113-2668142E-E8B2-452D-8AB9-E43CDE8D87F3Q49264094-1C50E53A-1245-421A-B810-27FD8125CC2F
P50
description
forsker
@nb
hulumtues
@sq
manager uit Israël
@nl
researcher from Israel
@en
רופא ומנהל רפואי
@he
name
Joshua Shemer
@ast
Joshua Shemer
@ca
Joshua Shemer
@da
Joshua Shemer
@de
Joshua Shemer
@en
Joshua Shemer
@es
Joshua Shemer
@fr
Joshua Shemer
@ga
Joshua Shemer
@nb
Joshua Shemer
@nn
type
label
Joshua Shemer
@ast
Joshua Shemer
@ca
Joshua Shemer
@da
Joshua Shemer
@de
Joshua Shemer
@en
Joshua Shemer
@es
Joshua Shemer
@fr
Joshua Shemer
@ga
Joshua Shemer
@nb
Joshua Shemer
@nn
altLabel
Shemer, Yehoshuʻa
@en
שמר, שוקי
@he
prefLabel
Joshua Shemer
@ast
Joshua Shemer
@ca
Joshua Shemer
@da
Joshua Shemer
@de
Joshua Shemer
@en
Joshua Shemer
@es
Joshua Shemer
@fr
Joshua Shemer
@ga
Joshua Shemer
@nb
Joshua Shemer
@nn
P214
P244
P268
P1375
P19
P21
P213
0000 0000 8001 1164
P214
P244
P268
P27
P31
P410
P569
1948-01-01T00:00:00Z
P735
P7859
lccn-n95800983